RxDoctor Payments DataLook up a doctor →

Nakita Stephens, MD

Neurology · Merriam, KSNPI 1861772097

Payments from drug & device makers

$8,688in general payments, 2019–2025

Across 631 payments — averaging $13.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Teva Pharmaceuticals USA, Inc.$499
  • MDD US Operations, LLC$438
  • UCB, Inc.$382
  • Biogen$374
  • Bristol Myers Squibb$342
  • plus $4K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)250$2,672
Teva Pharmaceuticals USA, Inc.77$499
MDD US Operations, LLC5$438
UCB, Inc.23$382
Biogen17$374
Bristol Myers Squibb35$342
Genentech USA, Inc.17$340
Abbott12$340
Novartis23$331
Pfizer27$233
Lilly USA, LLC10$191
Amgen11$182
Acadia Pharmaceuticals Inc9$176
Kyowa Kirin, Inc.9$163
EMD Serono, Inc.8$153
Argenx US, Inc.7$151
Jazz Pharmaceuticals Inc.7$139
Vanda Pharmaceuticals Inc.6$139
Biohaven Pharmaceuticals, Inc.10$126
Amneal Pharmaceuticals LLC6$111
Takeda Pharmaceuticals U.S.A., Inc.3$93
Neurelis, Inc.4$91
Sanofi4$89
Avion Pharmaceuticals5$87
Grifols USA, LLC4$87
Corium, LLC4$83
Catalyst Pharmaceuticals, Inc.3$77
Lundbeck LLC3$62
Merz Pharmaceuticals, LLC2$53
Otsuka America Pharmaceutical, Inc.3$52
SK Life Science, Inc.3$51
Eisai Inc.2$49
Hospira, Inc.3$47
Johnson & Johnson3$47
AstraZeneca2$33
Greenwich Biosciences, Inc.2$32
Banner Life Sciences, LLC2$32
Sunovion Pharmaceuticals Inc.2$26
Mallinckrodt Hospital Products Inc.1$23
CSL Behring1$18
Boston Scientific1$14
Adamas Pharmaceuticals, Inc.1$14
GE HealthCare1$12
E.r. Squibb & Sons, L.L.C.1$12
Aprecia Pharmaceuticals, LLC1$11
Neurocrine Biosciences, Inc.1$11

How this compares

$8,688 in reported general payments places this provider in the 70th percentile of 131 neurology providers in Kansas.

See all neurology providers in Kansas →

Medicare billing

Part B allowed, 2024
$73,966
Medicare patients
409
Services billed
541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Merriam

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →